Cancer drug shortage is costing lives
Spring 2011 : Cancer Drug Shortage Is Costing Lives
Cancer Drug Shortage Is Costing Lives
The number of critically important cancer drugs that are in short supply has tripled since 2005. Hagop Kantarjian, M.D., chair of MD Anderson's Leukemia Department, says drug shortages are affecting the survival of acute myeloid leukemia patients who depend on Cytarabine.
Guest: Hagop Kantarjian, M.D.
More Episodes From Cancer Newsline
Will Japan’s Nuclear Accident Effect Global Cancer Risk?